Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Panitumumab is the first fully human monoclonal antibody to Epidermal Growth Factor Receptor (EGFR) to enter clinical trials for the treatment of solid tumors. The anti-tumor activity of panitumumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in numerous ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Berardi, Rossana, Onofri, Azzurra, Pistelli, Mirco, Maccaroni, Elena, Scartozzi, Mario, Pierantoni, Chiara, Cascinu, Stefano
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963923/
https://www.ncbi.nlm.nih.gov/pubmed/21042543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963923/
https://www.ncbi.nlm.nih.gov/pubmed/21042543

Ejemplares similares